Pfizer postpones request with the FDA to approve COVID-19 vaccine for kids under 5
![Pfizer](https://cdn.mos.cms.futurecdn.net/Lbqf9ZMKqTPimqrzoLWSBj-415-80.jpg)
The approval of Pfizer's COVID-19 vaccine for children under five in the United States has hit a snag.
On Friday, Pfizer announced it's postponing its application with the Food and Drug Administration to approve its COVID-19 for children between the ages of 6 months and 4 years, NBC News reports.
Pfizer requested the FDA approve its COVID-19 vaccine for young children earlier this month. But the company said Friday it will wait for data from a study evaluating administering a third dose in this age group two months after the second dose.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
![https://cdn.mos.cms.futurecdn.net/flexiimages/jacafc5zvs1692883516.jpg](https://cdn.mos.cms.futurecdn.net/flexiimages/jacafc5zvs1692883516-320-80.jpg)
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
"Given that the study is advancing at a rapid pace, the companies will wait for the three-dose data as Pfizer and BioNTech continue to believe it may provide a higher level of protection in this age group," Pfizer and BioNTech said. "This is also supported by recent observations of three dose booster data in several other age groups that seems to meaningfully augment neutralizing antibody levels and real world vaccine protection for omicron compared to the two-dose regimen."
It's a delay in the timeline after it was previously reported that the vaccine could potentially be available for young kids by February.
At the same time, in what The New York Times described as a "striking reversal," the FDA announced Friday it has postponed a meeting of its Vaccines and Related Biological Products Advisory Committee to consider the Pfizer vaccine, originally scheduled for Feb. 15, as "we believe additional information regarding the ongoing evaluation of a third dose should be considered as part of our decision-making for potential authorization." The FDA said it will provide an update on the timing of the meeting when it receives the additional data from Pfizer, which Pfizer said is expected in early April.
Create an account with the same email registered to your subscription to unlock access.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Brendan worked as a culture writer at The Week from 2018 to 2023, covering the entertainment industry, including film reviews, television recaps, awards season, the box office, major movie franchises and Hollywood gossip. He has written about film and television for outlets including Bloody Disgusting, Showbiz Cheat Sheet, Heavy and The Celebrity Cafe.
-
How Black organizations quickly pivoted and mobilized for Kamala Harris
In the spotlight Harris has a shot at being the first Black woman to lead the Democratic ticket
By Theara Coleman, The Week US Published
-
Hamas and Fatah sign unity agreement in Beijing
Speed Read China brokered a reconciliation deal between the rival Palestinian factions
By Arion McNicoll, The Week UK Published
-
The Earth just saw its hottest day on record
Speed Read July 21, 2024 was the hottest day in recorded global history
By Rafi Schwartz, The Week US Published
-
Have we defeated malaria?
The Explainer Roll-out of low-cost vaccine means a world free from disease that claims 600,000 lives a year 'finally within sight'
By The Week UK Published
-
Brexit, Matt Hancock and black swans: five takeaways from Covid inquiry report
The Explainer UK was 'unprepared' for pandemic and government 'failed' citizens with flawed response, says damning report
By Harriet Marsden, The Week UK Published
-
Roll-out of affordable malaria vaccine begins
Speed Read R21 is approved for babies and may save hundreds of thousands of lives
By Arion McNicoll, The Week UK Published
-
Should masks be here to stay?
Talking Points New York Governor Kathy Hochul proposed a mask ban. Here's why she wants one — and why it may not make sense.
By Anya Jaremko-Greenwold, The Week US Published
-
Covid might be to blame for an uptick in rare cancers
The explainer The virus may be making us more susceptible to certain cancers
By Devika Rao, The Week US Published
-
Long Covid and chronic pain: is it all in the mind?
The Explainer 'Retraining the brain' could offer a solution for some long Covid sufferers
By The Week UK Published
-
Texas dairy worker gets bird flu from infected cow
Speed Read The virus has been spreading among cattle in Texas, Kansas, Michigan and New Mexico
By Peter Weber, The Week US Published
-
Dengue hits the Americas hard and early
Speed Read Puerto Rico has declared an epidemic as dengue cases surge
By Peter Weber, The Week US Published